Page 3 - GAPP Newsletter Issue 1 Jan2019
P. 3
Participants
MAIN PARTNER – COORDINATOR (1)
Istituto Superiore Di Sanita (Italy, project coordinator and WP1 leader)
ASSOCIATED PARTNERS (26):
Papageorgiou General Hospital (Greece, WP2 co-lead- Servicio Andaluz De Salud (Spain); Hospital of Lithuania
er); 7th Health Region Crete(Greece, WP2 co-leader); University of Health Sciences Kaunas Clinics (Lithuania);
Registrul National Al Donatorilor Voluntari De Celule Viesoji Istaiga Vilniaus Universiteto Ligonine Santaros
Stem Hematopoietice (Romania); Ministarstvo Zdravlia Klinikos (Lithuania); Ministry for Health - Government
Republike Hrvatske (Croatia, WP3 leader); Health and of Malta (Malta); Fondazione Irccs Ca’ Granda – Os-
Social Care Inspectorate, IVO (Sweden, WP4 leader); pedale Maggiore Policlinico (Italy, WP6 group responsi-
Health Products Regulatory Authority (Ireland, WP5 ble); Ministry of Human Capacities (Hungary)
leader); Organització Catalana de Trasplantaments,
OCATT (Spain, WP5 leader); Medicines and Healthcare COLLABORATING PARTNERS (14):
Products Regulatory Agency (United Kingdom, WP6
group responsible); Agence de la biomédecine (France, Hellenic National Blood Transfusion Center (Greece);
WP6 leader and WP7 co-leader); Laakealan Turval- Salar (Sweden); Fundatia Renala (Moldova); Etablisse-
lisuus-Ja Kehittamiskeskus (Finland, WP7 co-leader and ment francais du sang, EFS (France); Agence nationale
WP8 co-leader); Paul Ehrlich Institute (Germany, WP9 de sécurité du medicament et des produits de santé,
leader); Banc De Sang I Teixits (Spain, WP8 co-leader); ANSM (France); The State Agency of Medicines of the
Krajowe Centrum Bankowania Tkanek I Komorek (Po- Republic of Latvia (Latvia); European Society of Human
land, WP10 leader); Human Tissue Authority (United Reproduction and Embryolog (ESHRE); SOHO Consor-
Kingdom); Agentia De Transplant (Republic of Moldo- tium; European Centre for Disease Prevention and
va); Executive Agency For Transplantation (Bulgaria); Control (ECDC) (Sweden); European Hematology As-
Ministry of Health of the Republic of Cyprus (Cyprus); sociation (EHA); Institute for Transplantation and Bio-
Medical Products Agency (Sweden); Asociacion Es- medicine (Croatia); NHS Blood and Transplant, NHSBT
panola De Bancos De Tejidos (Spain); (United Kingdom); Joint Professional Advisory Commit-
tee, JPAC (United Kingdom); EDQM (France)
The GAPP JA website
The GAPP EU JA aiming at facilitating the development of a common and optimal approach to assess and authorize
preparation processes in blood and tissues establishments has developed its website (www.gapp-ja.eu) to raise
awareness about the project goals. With an attractive look, the GAPP JA website is easy and quick to navigate. It
presents general information regarding the JA aims, activities, and results, and the different partners of the con-
sortium. All the GAPP JA outputs, as well as the latest activities, news and events are uploaded on the website.
“This newsletter is part of the joint action ‘785269/GAPP’ which has received funding from the European Union’s Health Programme (2014- GAPP - Newsletter 1 3
2020). The content of this New-sletter represents the views of the author only and is his/her sole responsibility; it cannot be considered to
reflect the views of the European Commission and/or the Consu-mers, Health, Agriculture and Food Executive Agency or any other body of
the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the informa-
tion it contains”.

